arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MILESTONE SCIENTIFIC INC.

MLSS
$0.46 ▲ +0.01 (+2.58%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
17 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
10
Health
Poor
Bearish
auto_awesome

Analytical Summary

MILESTONE SCIENTIFIC INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $37.7M
Dividend Yield
Revenue Growth 4.0%
Op. Margin -63.5%
ROIC -160.0%
FCF / Share $-0.04
Trailing P/E
Price / Book 13.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.97M
↑ +4.0%
Net Income Profit after all expenses
$-5.72M
↓ -21.4%
Operating Margin Operating profit as % of sales
-63.5%
↑ +18.9% 4th
FCF / Share Free cash flow per share
$-0.04
↑ +2.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
2
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters